There is a lot happening in insulin sales that are providing benefits; it’s just that most patients aren’t the ones seeing those benefits. Scott Strumello is a consultant, writer, speaker and advocate with those living with T1D. Scott is passionate about getting real information to people by diving into medical data and scientific literature before drawing any conclusions. His ‘no-nonsense’ approach to facts-based reporting has led him to become an authority on all things diabetes investment with a dedicated following on social media. Jump into the episode and join us for a Scott's perspective on the business of insulin.[00:01 - 02:52] Opening SegmentI introduce Scott Strumello Scott shares his background and storyDiagnosed at age 7 Becoming active in the diabetes space The ‘business of diabetes’ [02:53 - 15:59] A No-Nonsense Perspective on the Business of InsulinScott talks about his current diabetes management Scott’s thoughts on state legislation The effects of Price CapsThe rebate mess A look into the GLP1 space Watching it for trendsScott shares about his audienceAn organic growth process Personal view on insulin Underwhelmed by the G6[16:00 - 28:01] Reimagining Insulin Legislation How Scott engages with opposition Scott’s view on apps Why most suck How Scott would do the legislation around insulin Transparency and pass through [28:02 - 30:35] Closing SegmentHow to connect with Scott Links below Final Words Tweetable Quotes:“I find that a lot of apps are developed, particularly by third party developers… I find most of those apps suck… they are solutions in search of a problem to solve.” - Scott Strumello “I think, first of all, transparency is valuable, but transparency alone isn’t going to ‘fix it’ for patients… Second of all, I think full pass-through of rebates to patients at the point of sale.” - Scott Strumello“I think most insulin is competed on for price, it’s just that most patients don’t get the benefit of it.” - Scott Strumello Connect with Scott on Twitter. Be sure to check out http://blog.sstrumello.com/ if you want to be up to date with all the latest in Diabetes. To know more, you can connect with me, David Kliff on Facebook, Twitter, and LinkedIn, or email me at [email protected]. Be sure to visit https://diabeticinvestor.com for more insights and real-time analyses on the evolving business of diabetes.Don’t be shy, I’d love to hear from you! You can also reach me at 224-715-3761.NOTE*: We are in no way a replacement for real medical professionals. All information in this podcast is obtained through reliable sources. Please be aware of our Disclaimer.LEAVE, SUBSCRIBE, REVIEW + help someone who wants to learn more about the wacky world of diabetes and everything happening within it.